Detalles de la búsqueda
1.
Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC.
JTO Clin Res Rep;
5(4): 100659, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596201
2.
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial).
Jpn J Clin Oncol;
2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520037
3.
Real-world Prognostic Data on Unresectable Stage III Non-small-cell Lung Cancer Treated with Concurrent Chemoradiation Therapy by Histological Type.
Intern Med;
2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346736
4.
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer.
Oncologist;
29(5): e681-e689, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241181
5.
Successful Treatment of ALK-Positive Large-Cell Neuroendocrine Carcinoma of the Lung With Sequential ALK Inhibitors: A Case Report.
JTO Clin Res Rep;
4(7): 100538, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37456922
6.
Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight.
Cancer Sci;
114(5): 2087-2097, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36704833
7.
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations.
Thorac Cancer;
13(11): 1703-1711, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491960
8.
Opioid-induced nausea and vomiting: a dexamethasone multicentre prospective study.
BMJ Support Palliat Care;
2022 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35443972
9.
Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy.
Transl Lung Cancer Res;
11(2): 135-149, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35280320
10.
Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): study protocol of a multicentre, real-world observational study.
BMJ Open;
12(1): e046451, 2022 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34983748
11.
Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non-small cell lung cancer.
Eur J Cancer;
160: 227-234, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34862083
12.
Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma.
Thorac Cancer;
12(11): 1668-1672, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33830645
13.
A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patients.
Int J Clin Oncol;
26(5): 851-857, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33656654
14.
Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin.
JTO Clin Res Rep;
1(3): 100046, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589942
15.
Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
J Thorac Dis;
11(6): 2350-2360, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31372272
16.
A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer.
Cancer Chemother Pharmacol;
84(2): 351-358, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993397
17.
Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case report.
Immunotherapy;
11(6): 467-472, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30727791
18.
Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations.
J Cancer Res Clin Oncol;
144(8): 1601-1611, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29858682
19.
Association Between Clinicopathological Features and Programmed Death Ligand 1 Expression in Non-small Cell Lung Cancer.
Anticancer Res;
38(2): 1077-1083, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29374744
20.
Chemoradiotherapy for unresectable cases of thymic epithelial tumors: a retrospective study.
J Thorac Dis;
9(10): 3911-3918, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29268401